title: Targeting mutant p53 for cancer therapy.
authors.affiliation: Department of Molecular Cell Biology, The Weizmann Institute, Rehovot 76100, Israel.
authors.forename: Moshe
authors.initials: M
authors.lastname: Oren
authors.affiliation: Department of Molecular Cell Biology, The Weizmann Institute, Rehovot 76100, Israel.
authors.forename: Perry
authors.initials: P
authors.lastname: Tal
authors.affiliation: Department of Molecular Cell Biology, The Weizmann Institute, Rehovot 76100, Israel.
authors.forename: Varda
authors.initials: V
authors.lastname: Rotter
mesh_terms: D000818:Animals; D016158:Genes, p53 / Q000235:genetics; D006801:Humans; D009154:Mutation; D009369:Neoplasms / Q000235:genetics*; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*
chemical_list: D016159:Tumor Suppressor Protein p53
keywords: MDM2; TP53; mutant p53 gain-of-function; peptide therapy; tumor suppressor